BTC Health Limited (BTC.AX)
AUD 0.07
(9.23%)
AUD 0.07
(9.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -2.02 Million AUD | -16.42% |
| 2023 | -1.73 Million AUD | 19.98% |
| 2022 | -2.17 Million AUD | 8.38% |
| 2021 | -2.36 Million AUD | 13.86% |
| 2020 | -2.75 Million AUD | 30.25% |
| 2019 | -3.94 Million AUD | -48.81% |
| 2018 | -2.64 Million AUD | 14.15% |
| 2017 | -3.08 Million AUD | -160.39% |
| 2016 | -1.18 Million AUD | -236.81% |
| 2015 | -351.89 Thousand AUD | -23.78% |
| 2014 | -284.28 Thousand AUD | 33.88% |
| 2013 | -429.95 Thousand AUD | 50.98% |
| 2012 | -877.02 Thousand AUD | 77.97% |
| 2011 | -3.98 Million AUD | -83.54% |
| 2010 | -2.16 Million AUD | 0.5% |
| 2009 | -2.18 Million AUD | 63.73% |
| 2008 | -6.01 Million AUD | 39.27% |
| 2007 | -9.89 Million AUD | -74.12% |
| 2006 | -5.68 Million AUD | 56.01% |
| 2005 | -12.92 Million AUD | -0.63% |
| 2004 | -12.83 Million AUD | 39.23% |
| 2003 | -21.12 Million AUD | -3748.09% |
| 2002 | -549 Thousand AUD | -120.48% |
| 2001 | -249 Thousand AUD | 99.38% |
| 2000 | -40.05 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -2.02 Million AUD | 0.0% |
| 2024 Q2 | -2.11 Million AUD | 0.0% |
| 2024 FY | -2.02 Million AUD | -16.42% |
| 2023 FY | -1.73 Million AUD | 19.98% |
| 2023 Q4 | -1.73 Million AUD | 0.0% |
| 2023 Q2 | -1.17 Million AUD | 0.0% |
| 2022 Q4 | -2.17 Million AUD | 0.0% |
| 2022 FY | -2.17 Million AUD | 8.38% |
| 2022 Q2 | -2.36 Million AUD | 0.0% |
| 2021 Q2 | -2.31 Million AUD | 0.0% |
| 2021 Q4 | -2.36 Million AUD | 0.0% |
| 2021 FY | -2.36 Million AUD | 13.86% |
| 2020 FY | -2.75 Million AUD | 30.25% |
| 2020 Q2 | -3.39 Million AUD | 0.0% |
| 2020 Q4 | -2.75 Million AUD | 0.0% |
| 2019 FY | -3.94 Million AUD | -48.81% |
| 2019 Q2 | -2.04 Million AUD | 0.0% |
| 2019 Q4 | -3.94 Million AUD | 0.0% |
| 2018 FY | -2.64 Million AUD | 14.15% |
| 2018 Q2 | -2.36 Million AUD | 0.0% |
| 2018 Q4 | -2.64 Million AUD | 0.0% |
| 2017 Q2 | -1 Million AUD | 0.0% |
| 2017 FY | -3.08 Million AUD | -160.39% |
| 2017 Q4 | -3.08 Million AUD | 0.0% |
| 2016 Q4 | -1.18 Million AUD | 0.0% |
| 2016 FY | -1.18 Million AUD | -236.81% |
| 2016 Q2 | -1.49 Million AUD | 0.0% |
| 2015 Q2 | -430.23 Thousand AUD | 0.0% |
| 2015 Q4 | -351.89 Thousand AUD | 0.0% |
| 2015 FY | -351.89 Thousand AUD | -23.78% |
| 2014 FY | -284.28 Thousand AUD | 33.88% |
| 2014 Q4 | -284.28 Thousand AUD | 0.0% |
| 2014 Q2 | -339.91 Thousand AUD | 0.0% |
| 2013 Q4 | -429.95 Thousand AUD | 0.0% |
| 2013 Q3 | -429.95 Thousand AUD | 15.76% |
| 2013 Q1 | -510.37 Thousand AUD | 41.81% |
| 2013 Q2 | -510.37 Thousand AUD | 0.0% |
| 2013 FY | -429.95 Thousand AUD | 50.98% |
| 2012 FY | -877.02 Thousand AUD | 77.97% |
| 2012 Q4 | -877.02 Thousand AUD | 0.0% |
| 2011 Q4 | -3.98 Million AUD | 0.0% |
| 2011 FY | -3.98 Million AUD | -83.54% |
| 2010 Q4 | -2.16 Million AUD | 0.0% |
| 2010 FY | -2.16 Million AUD | 0.5% |
| 2009 Q4 | -2.18 Million AUD | 0.0% |
| 2009 FY | -2.18 Million AUD | 63.73% |
| 2008 Q4 | -6.01 Million AUD | 0.0% |
| 2008 FY | -6.01 Million AUD | 39.27% |
| 2007 FY | -9.89 Million AUD | -74.12% |
| 2007 Q4 | -9.89 Million AUD | 0.0% |
| 2006 FY | -5.68 Million AUD | 56.01% |
| 2006 Q4 | -5.68 Million AUD | 0.0% |
| 2005 FY | -12.92 Million AUD | -0.63% |
| 2005 Q4 | -12.92 Million AUD | 0.0% |
| 2004 Q4 | -12.83 Million AUD | 0.0% |
| 2004 FY | -12.83 Million AUD | 39.23% |
| 2003 Q4 | -21.12 Million AUD | 0.0% |
| 2003 FY | -21.12 Million AUD | -3748.09% |
| 2002 FY | -549 Thousand AUD | -120.48% |
| 2002 Q4 | -22.4 Million AUD | 0.0% |
| 2001 Q4 | -29.06 Million AUD | 0.0% |
| 2001 FY | -249 Thousand AUD | 99.38% |
| 2000 FY | -40.05 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 89.3% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -105.9% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 139.906% |
| Biome Australia Limited | -1.56 Million AUD | -29.392% |
| Patrys Limited | -2.24 Million AUD | 9.752% |
| Orthocell Limited | -19.92 Million AUD | 89.851% |
| Imugene Limited | -91.56 Million AUD | 97.791% |
| Noxopharm Limited | -2.31 Million AUD | 12.835% |
| PYC Therapeutics Limited | -65.76 Million AUD | 96.925% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | 33.765% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 80.102% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 68.023% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 67.413% |
| CSL Limited | 15.76 Billion AUD | 100.013% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 84.096% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -184.988% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 98.895% |
| Starpharma Holdings Limited | -19.83 Million AUD | 89.804% |
| Nanollose Limited | -96.22 Thousand AUD | -2001.486% |
| Memphasys Limited | 4.13 Million AUD | 148.899% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 66.438% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 59.183% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -10.889% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 97.45% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -63.287% |
| Race Oncology Limited | -17.18 Million AUD | 88.236% |
| Nyrada Inc. | -4.76 Million AUD | 57.601% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 98.089% |
| Dimerix Limited | -21.99 Million AUD | 90.805% |
| PharmAust Limited | -9.71 Million AUD | 79.183% |
| Immutep Limited | -122.18 Million AUD | 98.345% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 98.519% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 83.797% |
| Acrux Limited | -1.45 Million AUD | -38.694% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 88.17% |
| Biotron Limited | -386.06 Thousand AUD | -423.782% |
| Tissue Repair Ltd | -16.44 Million AUD | 87.701% |
| AdAlta Limited | -845.17 Thousand AUD | -139.259% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 89.114% |
| Hexima Limited | -2.22 Million AUD | 9.166% |
| AnteoTech Limited | -5 Million AUD | 59.569% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 88.498% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | 40.457% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 62.056% |
| Actinogen Medical Limited | -9.13 Million AUD | 77.856% |
| Immuron Limited | -11.48 Million AUD | 82.391% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 87.292% |